This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
FK506 binding protein
From Proteopedia
| Line 35: | Line 35: | ||
===FKBP1=== | ===FKBP1=== | ||
| - | [[3mdy]] – hFKBP + BMPR1B<br /> | + | [[4iq2]], [[4iqc]] - hFKBP-1B (mutant)<br /> |
| + | [[4n19]] - hFKBP-1A (mutant)<br /> | ||
| + | [[3mdy]] – hFKBP-1A + BMPR1B<br /> | ||
[[3h9r]] - hFKBP-1A+ activin receptor type I<br /> | [[3h9r]] - hFKBP-1A+ activin receptor type I<br /> | ||
| - | [[1j4r]] – hFKBP-1+FKB-001 | + | [[4c02]] - hFKBP-1B+ activin receptor type I<br /> |
| + | [[1j4r]] – hFKBP-1+FKB-001<br /> | ||
| + | [[4dh0]] - hFKBP-1A+ rapamycin<br /> | ||
===FKBP3=== | ===FKBP3=== | ||
| Line 45: | Line 49: | ||
===FKBP4=== | ===FKBP4=== | ||
| - | [[1q1c]] – hFKBP <br /> | + | [[1q1c]], [[4lav]], [[4law]] – hFKBP <br /> |
[[1n1a]] – hFKBP N terminal<br /> | [[1n1a]] – hFKBP N terminal<br /> | ||
[[1p5q]] - hFKBP C terminal<br /> | [[1p5q]] - hFKBP C terminal<br /> | ||
| Line 56: | Line 60: | ||
[[3o5g]], [[3o5i]], [[3o5j]], [[3o5k]] - hFKBP FK506-binding domain<br /> | [[3o5g]], [[3o5i]], [[3o5j]], [[3o5k]] - hFKBP FK506-binding domain<br /> | ||
[[3o5l]], [[3o5m]], [[3o5o]], [[3o5p]], [[3o5q]] - hFKBP FK506-binding domain (mutant)<br /> | [[3o5l]], [[3o5m]], [[3o5o]], [[3o5p]], [[3o5q]] - hFKBP FK506-binding domain (mutant)<br /> | ||
| + | [[4lax]] – hFKBP + FK506<br /> | ||
| + | [[4lay]] – hFKBP + I63<br /> | ||
[[3o5r]] - hFKBP FK506-binding domain (mutant) + immunosuppressant<br /> | [[3o5r]] - hFKBP FK506-binding domain (mutant) + immunosuppressant<br /> | ||
[[4drq]] – hFKBP + pipecolate sulfonamide<br /> | [[4drq]] – hFKBP + pipecolate sulfonamide<br /> | ||
| Line 64: | Line 70: | ||
[[2f2d]], [[3ey6]], [[2awg]] - hFKBP FK506-binding domain<br /> | [[2f2d]], [[3ey6]], [[2awg]] - hFKBP FK506-binding domain<br /> | ||
[[2d9f]] – hFKBP – NMR<br /> | [[2d9f]] – hFKBP – NMR<br /> | ||
| - | [[2jwx]] | + | [[2mf9]], [[2jwx]] – hFKBP N terminal – NMR<br /> |
===FKBP12=== | ===FKBP12=== | ||
| Line 81: | Line 87: | ||
[[1tco]] - FKBP + Ser/Thr phosphatase B2 + immunosuppressant - bovine<br /> | [[1tco]] - FKBP + Ser/Thr phosphatase B2 + immunosuppressant - bovine<br /> | ||
[[1yat]] – FKBP + antagonist – yeast<br /> | [[1yat]] – FKBP + antagonist – yeast<br /> | ||
| + | [[2dg4]], [[1fkb]], [[1c9h]] - hFKBP+rapamycin<br /> | ||
| + | [[2fap]], [[1nsg]], [[1fap]] - hFKBP+rapamycin+FRB<br /> | ||
| + | [[1f40]] – hFKBP +GPI-1046<br /> | ||
| + | [[1a7x]] – hFKBP +FK-1012<br /> | ||
| + | [[1d7h]], [[1d7i]], [[1d7j]], [[1fkg]], [[1fkh]], [[1fki]] – hFKBP +ligand<br /> | ||
| + | [[4dh0]] – hFKBP + rapamycin<br /> | ||
| + | [[2rse]] – hFKBP + serine/threonine protein kinase MTOR peptide + rapamycin - NMR<br /> | ||
| + | [[2dg9]] - hFKBP (mutant)+rapamycin<br /> | ||
| + | [[1fkl]] – cFKBP +rapamycin – cow<br /> | ||
[[3uqi]] – ymFKBP – yellowfever mosquito<br /> | [[3uqi]] – ymFKBP – yellowfever mosquito<br /> | ||
[[2lpv]] – ymFKBP - NMR<br /> | [[2lpv]] – ymFKBP - NMR<br /> | ||
| + | |||
| + | ===FKBP13=== | ||
| + | |||
| + | [[2pbc]] – hFKBP <br /> | ||
| + | [[4nnr]] – hFKBP + FK506<br /> | ||
| + | [[1y0o]], [[1u79]] – AtFKBP - ''Arabidopsis thaliana'' | ||
| + | |||
| + | ===FKBP14=== | ||
| + | |||
| + | [[4dip]], [[4msp]] – hFKBP <br /> | ||
| + | |||
| + | ===FKBP22=== | ||
| + | |||
| + | [[3b09]] – FKBP N terminal - ''Shewanella''<br /> | ||
| + | |||
| + | ===FKBP25=== | ||
| + | |||
| + | [[2kfv]] – hFKBP N terminal<br /> | ||
| + | [[1pbk]] – hFKBP C terminal<br /> | ||
===FKBP26=== | ===FKBP26=== | ||
| Line 91: | Line 125: | ||
[[2vn1]] – PfFKBP FK506-binding domain+FK506 <br /> | [[2vn1]] – PfFKBP FK506-binding domain+FK506 <br /> | ||
| + | [[4j4n]] – PfFKBP FK506-binding domain+ antimalarial drug <br /> | ||
===FKBP36=== | ===FKBP36=== | ||
| Line 109: | Line 144: | ||
[[1kt0]], [[1kt1]] – hFKBP<br /> | [[1kt0]], [[1kt1]] – hFKBP<br /> | ||
[[4drq]] – hFKBP + pipecolate sulfonamide<br /> | [[4drq]] – hFKBP + pipecolate sulfonamide<br /> | ||
| + | [[4jfi]], [[4jfj]], [[4jfk]], [[4jfl]], [[4jfm]] – hFKBP (mutant) + inhibitor<br /> | ||
[[4drk]], [[4drm]], [[4drn]], [[4dro]], [[4drp]] – hFKBP + FK506 analog<br /> | [[4drk]], [[4drm]], [[4drn]], [[4dro]], [[4drp]] – hFKBP + FK506 analog<br /> | ||
[[4drh]], [[4dri]] – hFKBP FK1 domain + serine/threonine protein kinase MTOR peptide + rapamycin <br /> | [[4drh]], [[4dri]] – hFKBP FK1 domain + serine/threonine protein kinase MTOR peptide + rapamycin <br /> | ||
Revision as of 11:00, 10 March 2014
| |||||||||||
Contents |
3D Structures of FKBP
Updated on 10-March-2014
FKBP
1fks, 1fkr, 1fkt – EcFKBP – Escherichia coli
1q6h, 1q6u – EcFKBP
1q6i – EcFKBP+FK-506
1ix5 – FKBP – Methanothermococcus thermolithotrophicus – NMR
1bl4 – hFKBP (mutant)+inhibitor
1bkf – hFKBP (mutant)+FK-506
1fkf - hFKBP+FK-506
1fkr, 1fks, 1fkt – hFKBP - NMR
FKBP1
4iq2, 4iqc - hFKBP-1B (mutant)
4n19 - hFKBP-1A (mutant)
3mdy – hFKBP-1A + BMPR1B
3h9r - hFKBP-1A+ activin receptor type I
4c02 - hFKBP-1B+ activin receptor type I
1j4r – hFKBP-1+FKB-001
4dh0 - hFKBP-1A+ rapamycin
FKBP3
3kz7 – hFKBP FK506-binding domain + immunosuppressant - human
FKBP4
1q1c, 4lav, 4law – hFKBP
1n1a – hFKBP N terminal
1p5q - hFKBP C terminal
1qz2 – hFKBP + Hsp90 peptide
4drj – hFKBP FK506-binding domain + serine/threonine-protein kinase FRB domain + Immunospressant
FKBP5
3o5d, 3o5e, 3o5f – hFKBP
3o5g, 3o5i, 3o5j, 3o5k - hFKBP FK506-binding domain
3o5l, 3o5m, 3o5o, 3o5p, 3o5q - hFKBP FK506-binding domain (mutant)
4lax – hFKBP + FK506
4lay – hFKBP + I63
3o5r - hFKBP FK506-binding domain (mutant) + immunosuppressant
4drq – hFKBP + pipecolate sulfonamide
4drk, 4drm, 4drn, 4dro, 4drp – hFKBP FK506-binding domain + FK506 analog
FKBP8
2f2d, 3ey6, 2awg - hFKBP FK506-binding domain
2d9f – hFKBP – NMR
2mf9, 2jwx – hFKBP N terminal – NMR
FKBP12
1eym, 2ppo, 4ipx – hFKBP (mutant)
1fkk – hFKBP
2gaq, 2pnu– hFKBP - NMR
3uqi – ymFKBP – yellowfever mosquito
2lpv – ymFKBP - NMR
1fkd, 1fkj, 2fke, 1qpf, 1qpl – hFKBP + immunosuppressant
2ppp, 2ppn, 2dg3, 1d6o – hFKBP
1j4h, 1j4i – hFKBP + inhibitor
1b6c – hFKBP + TGF-B superfamily receptor I
3fap – hFKBP + FKBP12-rapamycin associated protein
4fap - hFKBP + FKBP12-rapamycin associated protein + immunosuppressant
1tco - FKBP + Ser/Thr phosphatase B2 + immunosuppressant - bovine
1yat – FKBP + antagonist – yeast
2dg4, 1fkb, 1c9h - hFKBP+rapamycin
2fap, 1nsg, 1fap - hFKBP+rapamycin+FRB
1f40 – hFKBP +GPI-1046
1a7x – hFKBP +FK-1012
1d7h, 1d7i, 1d7j, 1fkg, 1fkh, 1fki – hFKBP +ligand
4dh0 – hFKBP + rapamycin
2rse – hFKBP + serine/threonine protein kinase MTOR peptide + rapamycin - NMR
2dg9 - hFKBP (mutant)+rapamycin
1fkl – cFKBP +rapamycin – cow
3uqi – ymFKBP – yellowfever mosquito
2lpv – ymFKBP - NMR
FKBP13
2pbc – hFKBP
4nnr – hFKBP + FK506
1y0o, 1u79 – AtFKBP - Arabidopsis thaliana
FKBP14
FKBP22
3b09 – FKBP N terminal - Shewanella
FKBP25
2kfv – hFKBP N terminal
1pbk – hFKBP C terminal
FKBP26
3pr9, 3pra, 3prb, 3prd – FKBP – Methanocaldococcus jannaschii
FKBP35
2vn1 – PfFKBP FK506-binding domain+FK506
4j4n – PfFKBP FK506-binding domain+ antimalarial drug
FKBP36
3b7x – hFKBP
FKBP38
2jwx - hFKBP N terminal - NMR
FKBP42
2f4e – AtFKBP N-terminal
2if4 – AtFKBP
FKBP51
1kt0, 1kt1 – hFKBP
4drq – hFKBP + pipecolate sulfonamide
4jfi, 4jfj, 4jfk, 4jfl, 4jfm – hFKBP (mutant) + inhibitor
4drk, 4drm, 4drn, 4dro, 4drp – hFKBP + FK506 analog
4drh, 4dri – hFKBP FK1 domain + serine/threonine protein kinase MTOR peptide + rapamycin
FKBP52
4drj – hFKBP FK1 domain + serine/threonine protein kinase MTOR peptide + rapamycin
FKBP59
1rot, 1rou – FKBP N terminal – NMR – rabbit
2kr7 – FKBP SlyD – NMR - Helicobacter pylori
2lgo – FKBP – NMR –Giardia lamblia
FKBP73
References
- ↑ Unger T, Dym O, Albeck S, Jacobovitch Y, Bernehim R, Marom D, Pisanty O, Breiman A. Crystal structure of the three FK506 binding protein domains of wheat FKBP73: evidence for a unique wFK73_2 domain. J Struct Funct Genomics. 2010 Jun;11(2):113-23. Epub 2010 Mar 20. PMID:20306145 doi:10.1007/s10969-010-9085-8
- ↑ Cheng T, Li H, Xia W, Sun H. Multifaceted SlyD from Helicobacter pylori: implication in [NiFe] hydrogenase maturation. J Biol Inorg Chem. 2011 Nov 2. PMID:22045417 doi:10.1007/s00775-011-0855-y

